Profound Medical Corp. PRN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.61% | -21.73% | -53.04% | -24.77% | -46.88% |
| Total Depreciation and Amortization | -35.05% | -41.46% | -40.17% | -11.67% | -11.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.47% | 85.93% | 94.50% | 44.53% | 5.36% |
| Change in Net Operating Assets | -655.89% | -738.57% | -389.85% | -232.98% | 58.91% |
| Cash from Operations | -3.94% | -41.53% | -62.91% | -50.66% | -54.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 88.67% | 49.01% | -0.12% |
| Issuance of Common Stock | 8.24% | 8.24% | -31.71% | 70.91% | 70.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.53% | 66.53% | 79.24% | -63.31% | -63.31% |
| Cash from Financing | 19.90% | 22.03% | -24.79% | 84.37% | 77.51% |
| Foreign Exchange rate Adjustments | -255.14% | 179.40% | 183.41% | 111.80% | 157.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 175.63% | -26.48% | -83.24% | 64.67% | 121.48% |